The At1g30720 antibody (product code CSB-PA193228XA01DOA) is a polyclonal antibody produced against the At1g30720 gene product. It is commercially available through Cusabio, with specificity validated for Arabidopsis thaliana .
The At1g30720 gene encodes a protein of unknown function, classified as an "unknown protein" in Arabidopsis genomic databases. Research highlights its regulatory role in abscisic acid (ABA) signaling pathways:
In transgenic Arabidopsis lines (RL-BK L1 and L3), At1g30720 expression was significantly downregulated compared to vector control plants :
| Experiment | Expression Ratio (Transgenic/Control) | P Value 1 | P Value 2 |
|---|---|---|---|
| Untreated RL-BK L1 | 0.12 (±0.04) | 4.7 × 10⁻²⁶ | 1.3 × 10⁻²³ |
| Untreated RL-BK L3 | 0.19 (±0.00) | 1.2 × 10⁻²¹ | 1.5 × 10⁻²¹ |
Interpretation: The strong downregulation (P < 0.005) suggests that At1g30720 may act as a negative regulator of ABA signaling or participate in stress-response pathways .
The At1g30720 antibody enables:
Protein Localization: Mapping tissue-specific expression in Arabidopsis roots, leaves, or floral tissues.
Mechanistic Studies: Investigating interactions with ABA-related kinases or phosphatases.
Mutant Validation: Confirming knockout or overexpression lines via Western blotting.
While the antibody is well-characterized commercially, functional studies of the At1g30720 protein remain limited. Future work could explore:
At1g30720 antibody is a research reagent that specifically recognizes the protein encoded by the At1g30720 gene in Arabidopsis thaliana. This gene encodes a protein involved in plant cellular processes. The antibody allows researchers to detect, quantify, and isolate this protein in experimental settings. When designing experiments, researchers should consider the antibody's species specificity, clonality (monoclonal or polyclonal), and the specific epitope it recognizes .
The At1g30720 antibody can be utilized in multiple immunoassay techniques commonly employed in plant research. These typically include Western blotting, immunoprecipitation, immunohistochemistry, ELISA, and flow cytometry. For immunoprecipitation applications, researchers should follow established protocols, including proper preparation of antibody-protein A/G agarose beads, careful preparation of cell extracts, and appropriate washing steps to minimize non-specific binding .
Proper storage and handling are crucial for maintaining antibody activity. Most research antibodies, including At1g30720 antibody, should be stored at -20°C for long-term storage and 4°C for short-term use. Avoid repeated freeze-thaw cycles by making small aliquots upon receipt. The working concentration typically ranges from 1-10 μg/ml depending on the specific application. When preparing for immunoprecipitation, adjust antibody concentration to 5-10 μg/ml in PBS before binding to protein A/G agarose beads .
Validation of antibody specificity is essential for reliable experimental results. For At1g30720 antibody, researchers should:
Perform Western blot analysis using wild-type and At1g30720 knockout plant tissues
Include competitive binding assays with purified recombinant target protein
Conduct immunostaining with appropriate positive and negative controls
Verify cross-reactivity with homologous proteins in related species
For functional validation, similar to other receptor antibodies, researchers could utilize cell-based luminometric assays with cells expressing the target protein and measure inhibitory or stimulatory effects of the antibody .
Proper controls are critical for interpretable immunoprecipitation results. Researchers should include:
Isotype-matched irrelevant control antibody or non-immunized serum from the same species to identify non-specific binding
Input control (pre-immunoprecipitation lysate) to confirm target protein presence
Negative control using lysate from tissues not expressing the target protein
Positive control using lysate with known expression of the target protein
These controls help distinguish specific from non-specific interactions. Note that extended incubation periods may increase background due to time-dependent aggregation or denaturation of cellular proteins .
Cross-reactivity assessment is important when extending research to related plant species. Researchers should:
Perform Western blot analysis with protein extracts from multiple plant species
Quantify binding affinity differences across species
Conduct epitope mapping to identify conserved regions
Test antibody performance in different tissue types from various species
Similar to tissue cross-reactivity studies in other fields, testing the antibody at multiple concentrations (typically low and high concentrations) helps differentiate specific from non-specific binding patterns .
High background is a frequent challenge in Western blotting. For At1g30720 antibody, potential causes include:
| Problem | Possible Cause | Solution |
|---|---|---|
| Non-specific binding | Insufficient blocking | Increase blocking time or change blocking agent |
| High antibody concentration | Excessive primary antibody | Titrate antibody to optimal concentration (typically 1-5 μg/ml) |
| Cross-reactivity | Antibody recognizing similar epitopes | Pre-absorb antibody with non-target proteins |
| Contaminated buffers | Bacterial growth in buffers | Prepare fresh buffers with proper antimicrobial agents |
| Insufficient washing | Residual unbound antibody | Increase number and duration of wash steps |
For improved specificity, consider using more stringent washing conditions and optimizing antibody concentration through titration experiments .
Optimization of immunoprecipitation protocols for At1g30720 antibody may require adjustments to several parameters:
Lysis buffer composition: The choice depends on protein localization (membrane, cytosolic, nuclear). For membrane-associated plant proteins, consider buffers containing 1% NP-40 or Triton X-100.
Antibody-bead ratio: Test different ratios of antibody to beads (typically 5-10 μg antibody per 5-10 μl beads).
Incubation time: Balance between sufficient binding (1-2 hours) and minimizing non-specific interactions.
Washing stringency: Adjust salt concentration and detergent levels in wash buffers.
Elution conditions: Test different elution methods, including low pH, high salt, or competitive elution .
When facing weak signal detection with At1g30720 antibody, researchers can implement several strategies:
Sample enrichment: Concentrate the target protein through subcellular fractionation or preliminary immunoprecipitation.
Signal amplification: Employ more sensitive detection systems like enhanced chemiluminescence (ECL) or fluorescent secondary antibodies.
Antibody concentration: Increase primary antibody concentration while monitoring background levels.
Incubation conditions: Extend incubation time or adjust temperature.
Epitope retrieval: For fixed tissues, optimize antigen retrieval methods to improve epitope accessibility.
For Western blot applications specifically, reducing SDS concentration in transfer buffer can improve protein binding to membranes for certain targets .
At1g30720 antibody can be leveraged for investigating protein-protein interactions through several advanced approaches:
Co-immunoprecipitation: Precipitate the target protein using At1g30720 antibody and identify interacting partners through mass spectrometry.
Proximity labeling: Conjugate the antibody with enzymes like BioID or APEX2 to label proteins in close proximity to the target.
Chromatin immunoprecipitation (ChIP): If the protein interacts with DNA, use the antibody to precipitate protein-DNA complexes.
Förster resonance energy transfer (FRET): Combine with fluorescently labeled secondary antibodies for in situ interaction studies.
These approaches require careful optimization of antibody-to-sample ratios and washing conditions to minimize false positives while maintaining true interactions .
Similar to other research antibodies, At1g30720 antibody can be engineered for enhanced functionality:
pH-dependent binding: Engineering the antibody for pH-dependent antigen binding can create a "sweeping antibody" that more effectively eliminates antigens from solution, similar to natural endocytic receptor functions.
Increased FcRn binding: Modifications to enhance binding to the neonatal Fc receptor at neutral pH can improve antibody recycling and extend half-life.
Fluorophore conjugation: Direct labeling with fluorescent molecules eliminates the need for secondary antibodies.
Enzyme conjugation: Attachment of enzymes like HRP or biotin ligase enables direct detection or proximity labeling.
These modifications can dramatically enhance experimental capabilities and efficiency for plant protein research .
For in vivo imaging applications in plant research, At1g30720 antibody can be adapted through several approaches:
Fluorophore conjugation: Direct labeling with bright, photostable fluorophores enables live-cell imaging.
Quantum dot attachment: Provides enhanced brightness and photostability for extended imaging sessions.
Antibody fragment generation: Creating Fab or single-chain variable fragments improves tissue penetration.
Nanobody development: Developing camelid-derived single-domain antibodies against the same epitope can provide superior tissue access.
When designing such experiments, researchers must verify that modifications do not affect binding specificity or affinity through appropriate control experiments .
When facing contradictory results across different immunoassay platforms, consider the following analytical approach:
Assay-specific limitations: Each technique has unique strengths and weaknesses. Western blots denature proteins while immunoprecipitation preserves native conformations.
Epitope accessibility: The target epitope may be differentially accessible in different assay conditions.
Post-translational modifications: Different assays may detect different modified forms of the protein.
Antibody cross-reactivity: Verify specificity in each experimental system independently.
Protocol optimization: Techniques may require different optimization parameters for the same antibody.
Creating a systematic comparison table of results across methods can help identify patterns that explain discrepancies .
Quantitative analysis of At1g30720 protein expression requires rigorous methodological approaches:
Quantitative Western blotting: Use housekeeping proteins as loading controls and digital image analysis for densitometry.
ELISA development: Establish a standard curve using recombinant protein for absolute quantification.
Multiple antibody validation: Employ antibodies recognizing different epitopes to confirm specificity.
Mass spectrometry validation: Combine immunoprecipitation with mass spectrometry for orthogonal validation.
When comparing expression across tissues, normalize to total protein content rather than single reference proteins, as housekeeping protein expression may vary across tissue types .
Distinguishing specific from non-specific binding requires systematic analysis:
Concentration titration: Test the antibody at multiple concentrations (typically low and high) to identify high-affinity interactions.
Competitive inhibition: Pre-incubate with purified antigen to block specific binding sites.
Knockout controls: Compare binding patterns in wild-type versus knockout tissues.
Multiple detection methods: Confirm results using orthogonal detection techniques.
For tissues showing unexpected reactivity, conduct epitope mapping to determine if cross-reactive proteins share sequence homology with the target. Testing at lower antibody concentrations helps identify high-affinity interactions relevant to potential specificity, while higher concentrations help understand binding saturation properties .